Geron Investors Get Lead Plaintiff in Cancer Drug Fight

Geron Corp. investors who accused the company of misleading them about a bone marrow cancer drug trial had their cases consolidated in California federal district court and secured a lead plaintiff.

The two complaints share the same class period, make the same claims, and allege the same misstatements, so consolidation is appropriate, the U.S. District Court for the Northern District of California said Thursday. Julia and Richard Junge beat out seven others for the lead plaintiff role.

Five of the eight parties withdrew their motions for appointment, and a sixth filed a statement of non-opposition, Judge William Alsup’s order said. ...